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Comprehensive analysis of the mammalian transcriptome has revealed that long non-
coding RNAs (lncRNAs) may make up a large fraction of cellular transcripts. Recent years
have seen a surge of studies aimed at functionally characterizing the role of lncRNAs in
development and disease. In this review, we discuss new ﬁndings implicating lncRNAs in
controlling development of the central nervous system (CNS). The evolution of the higher
vertebrate brain has been accompanied by an increase in the levels and complexities of
lncRNAs expressed within the developing nervous system. Although a limited number of
CNS-expressed lncRNAs are now known to modulate the activity of proteins important for
neuronal differentiation, the function of the vast majority of neuronal-expressed lncRNAs
is still unknown. Topics of intense current interest include the mechanism by which
CNS-expressed lncRNAs might function in epigenetic and transcriptional regulation during
neuronal development, and how gain and loss of function of individual lncRNAs contribute
to neurological diseases.
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IDENTIFICATION, CONSERVATION, AND DIVERSITY OF
lncRNAs
Annotation and high-throughput deep sequencing of the tran-
scriptomes of multiple species have led to the belief that much
of the genome is transcribed; however, only a minority of tran-
scribed sequences contain evolutionarily conserved open reading
frames (Okazaki et al., 2002; Maeda et al., 2006; Kapranov et al.,
2007, 2010; Derrien et al., 2012; Dunham et al., 2012). Many
of the transcribed sequences are thus unlikely to encode pro-
teins. Among all human non-coding transcripts, at least 10,000
are estimated to be >200 nucleotides, and are accordingly des-
ignated as long non-coding RNAs (lncRNAs; Derrien et al.,
2012). Based on transcriptome analysis of protein coding genes
(Okazaki et al., 2002), transcripts are typically classiﬁed as lncR-
NAs when they do not contain any open reading frame >100
amino acids in length. Although few lncRNAs contain ORFs
longer than predicted by pure chance (Dinger et al., 2008, 2011),
they also show relatively low levels of evolutionary conservation
overall, suggesting that they may encode short, evolutionar-
ily divergent proteins similar to those observed in Drosophila
(Kondo et al., 2010). Recently, researchers detected a number of
evolutionarily conserved sequences that do encode small pro-
teins through both ribosome proﬁling and mass spectrometry
(Bazzini et al., 2014). However, analysis of other mass spectrom-
etry experiments reveals that lncRNAs rarely produce detectable
protein products (Banfai et al., 2012; Slavoff et al., 2013). Fur-
thermore, ribosome proﬁling experiments have indicated that
while lncRNAs can associate with ribosomes, ribosome occupancy
of lncRNAs displays features more congruent with untranslated
regions (5′ UTRs) and other classical ncRNAs, such as small
nucleolar RNAs (snoRNAs) and microRNAs (miRNAs; Guttman
et al., 2013). Combined with data showing that a large frac-
tion of lncRNA transcripts are retained in the nucleus (Derrien
et al., 2012), it suggests that lncRNAs impart functions as RNA
transcripts.
LncRNAs are distinguished from other ncRNAs subtypes by
several different features. Inherent to the name, lncRNAs are
classiﬁed as such based on a length of >200 nucleotides, distin-
guishing them from many ncRNAs including miRNAs, snoRNAs,
and others. They are also distinct from transfer RNAs (tRNAs)
as they are typically transcribed by RNA polymerase II (RNA
Pol II), as opposed to RNA Pol III. Moreover, lncRNAs share
many features with protein-coding messenger RNAs (mRNAs) –
they are capped and polyadenylated. Many lncRNAs also contain
multiple exons and are subjected to alternative splicing. How-
ever, in comparison to protein-coding transcripts, lncRNAs are
roughly one-third as long, contain fewer exons (∼2.8 exons in
lncRNAs compared to 11 exons for protein coding genes), and
are expressed at 10-fold lower levels on average (Guttman et al.,
2010; Cabili et al., 2011; Pauli et al., 2012). In addition, lncRNAs
show a higher degree of tissue-speciﬁc expression than do protein-
coding genes (Cabili et al., 2011). Compared to protein-coding
genes, retrotransposon sequences and tandem repeat elements
are more frequently included in lncRNA sequences (Ulitsky et al.,
2011; Kelley and Rinn, 2012). These elements have been pro-
posed to facilitate lncRNA function through either base pairing
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with other RNAs with similar repeat sequences, or through as yet
unidentiﬁed mechanisms (Gong and Maquat, 2011; Carrieri et al.,
2012).
The discovery that much of the genome is transcribed bi-
directionally has led to a diverse and still not fully standard-
ized categorization of lncRNAs based on genomic localization.
Included in the class of lncRNAs are enhancer-related lncR-
NAs (eRNAs) or transcribed ultra-conserved region lncRNAs
(Figure 1A), intronic lncRNAs (Figure 1B), large/long intergenic
or intervening non-coding RNAs (lincRNAs; Figure 1C), pro-
moter associated lncRNAs (Figure 1D), and natural antisense
transcripts (NATs; Figure 1E). LincRNAs have been identiﬁed
through examination of sequencing reads that map expressed
transcripts without clearly deﬁned ORFs to intergenic regions.
These lincRNAs usually also possess signatures of active tran-
scription including H3K4me3, polyadenylation signals, and RNA
polymerase II occupancy (Guttman et al., 2009). LncRNAs not
localized to intergenic regions have been less readily identiﬁed and
originally described as transcription “noise” due to overlap with
protein-coding transcripts or known DNA-regulatory elements
such as enhancers.
Reports suggest that intronic lncRNAs, which comprise up to
35% of non-coding transcripts, form the largest single class of
lncRNAs (Birney et al., 2007; St Laurent et al., 2012). Although
intronic lncRNAs were originally thought to be unprocessed
pre-mRNAs of protein coding genes, current estimates suggest
that up to 80% of protein coding loci have transcriptionally
active introns that are expressed independently from the pro-
tein coding pre-mRNA (Dermitzakis et al., 2005; Louro et al.,
2008; St Laurent et al., 2012). Further conﬁrmation of the pres-
ence of intronic lncRNAs comes from reports that ﬁnd many
intronic lncRNAs localized to the cytoplasm, excluding the pos-
sibilities that intronic lncRNAs are the result of genomic DNA
or unspliced pre-mRNA contamination in deep sequencing stud-
ies (Kampa et al., 2004; Kapranov et al., 2007; Mercer et al.,
2008). Intronic lncRNAs are transcribed from either the sense
or antisense strand of the protein-coding gene in which they
are encoded, further supporting independent transcriptional reg-
ulation (Rinn et al., 2003; Bertone et al., 2004; Kampa et al.,
2004).
A relatively new class of ncRNAs, eRNAs, result from
bidirectional transcription of enhancers. These sequences dis-
play H3K4me1 and H3K27ac modiﬁcations, and p300/CBP
and RNA polymerase II occupancy, and thus show signa-
tures of open or poised chromatin (Heintzman et al., 2007,
2009; Visel et al., 2009; De Santa et al., 2010; Kim et al.,
2010; Orom et al., 2010). While many eRNAs are short
(<200 nt), there are a considerable number of lncRNAs that
display lincRNA-like chromatin signatures and overlap known
enhancer sequences. Because of the shared enhancer sequence,
these have been further classiﬁed as transcribed ultra-conserved
region-associated lncRNAs to distinguish them from shorter
eRNAs.
NATs, on the other hand,were identiﬁed inbacteria and eukary-
otes in the 1990s (Wagner and Simons, 1994; Vanhee-Brossollet
and Vaquero, 1998). More recent studies indicate that 50–70% of
protein coding genes are also transcribed in the antisense direc-
tion, with half of these antisense transcripts being non-coding
(Carninci et al., 2005; Katayama et al., 2005; Galante et al., 2007).
Studies have shown that many NATs display localized expres-
sion patterns that correspond inversely with their sense transcript
counterparts, suggesting possible negative regulation of sense
transcripts by NATs (Vanhee-Brossollet andVaquero, 1998; Alfano
et al., 2005). In contrast, many lncRNAs without overlapping
sequence display expression patterns that correlate with nearby
protein-coding transcripts (Luo et al., 2013).
FIGURE 1 | Classification of lncRNAs based on genomic localization.
Schematic examples of the classiﬁcation of lncRNAs based on genomic
localization. (A) Enhancer-associated RNAs result from direct, bi-directional
transcription of enhancer elements Ultra-conserved enhancer elements are
frequently transcribed as part of lncRNA sequences. (B) Intronic lncRNAs
localize to the introns of protein-coding genes and are transcribed from the
anti-sense (pictured) or sense strand (not shown). (C) LincRNAs are localized
to gene deserts, far removed from proximal promoter elements from
neighboring protein-coding genes. (D) Promoter associated lncRNAs are
transcribed from segments within proximal promoters of the associated
protein-coding gene on the anti-sense (opposite strand lncRNAs; shown) or
sense (not shown) strand relative to the protein-coding gene. (E) Natural
antisense lncRNAs are transcribed for the antisense strand of protein-coding
genes and contain complementary sequences to segments of the mature
mRNA. Protein-coding exons shown in yellow; lncRNA exons shown in red;
overlapping sequence shown in purple.
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Despite the tremendous diversity of lncRNAs, their func-
tional importance has been underappreciated and relatively
understudied, in part due to the fact that they often fail to
show clear evolutionary conservation (Ulitsky et al., 2011; Basu
et al., 2013). However, previous comparative genomic analyses
have identiﬁed thousands of non-coding intergenic and intronic
ultra-conserved sequence elements (UCEs) in the human genome
(Bejerano et al., 2004; Sandelin et al., 2004). Analysis of the
genomic localization of UCEs shows that UCEs are preferentially
localized to loci encoding DNA-binding proteins (Sandelin et al.,
2004). A recent study that incorporated transcriptome data from
many different vertebrate species revealed that 4–11% of lncR-
NAs are conserved across the vertebrate lineage, and many of
these map to UCE loci (Ulitsky et al., 2011; Basu et al., 2013).
Additionally, although the primary sequence of lincRNAs that are
localized in close proximity to protein-coding genes often shows
little sequence conservation, synteny between vertebrate lincRNAs
andprotein-coding genes is often conservedduring vertebrate evo-
lution (Ulitsky et al., 2011; Qu and Adelson, 2012a,b). Combined,
this suggests that the synteny and evolutionary conservation of
these non-coding elements helps facilitate the regulated expres-
sion of transcription factors through enhancer activity, functional
ncRNA transcripts, or both.
Analysis of sequence conservation within transcribed and reg-
ulatory regions of individual lncRNAs suggest that the proximal
promoters display highest levels of evolutionary conservation
(Carninci, 2007; Ponjavic et al., 2007; Marques and Ponting, 2009;
Chodroff et al., 2010). Peak conservation is observed ∼43 bp
upstream of the transcription start site, similar to the level of
conservation seen across mouse and human protein coding genes
(Taylor et al., 2006; Chodroff et al., 2010). Furthermore, exonic
sequence of lncRNAs is more highly conserved than intronic
sequence, with exon splice sites showing highest evolutionary con-
straint (Chodroff et al., 2010). Short sequenceswithin the lncRNAs
are also frequently conserved. Stringent identiﬁcations of miR-
NAs localized within lncRNA sequence identiﬁed 97 lncRNAs
that function as potential precursors to miRNA clusters (He et al.,
2008). These miRNA sequences display a minimum 98% homol-
ogy between rat and mouse, a far greater sequence conservation
than observed for lncRNAs as a whole (He et al., 2008).
Quantiﬁcation of the number of lncRNAs present across multi-
ple species has elicited a wide range of estimates for the number of
vertebrate lncRNAs. Stringent estimates suggest that 1133 lncR-
NAs are expressed during zebraﬁsh development (Pauli et al.,
2012). Consistent with an evolutionary increase in number, size,
and divergence of regulatory elements as species become more
complex (Mazumder et al., 2003; Frith et al., 2005; Taft et al.,
2007), conservative estimates from recent GENCODE sequencing
builds in mouse and humans (July, 2013) indicate the pres-
ence of 4074 and 13,870 lncRNAs, respectively (Derrien et al.,
2012; Harrow et al., 2012). Estimates from mouse suggest that
849 of the 1328 lncRNAs examined by in situ hybridization
show speciﬁc expression patterns in the adult brain (Mercer
et al., 2008). More comprehensive analysis using RNA deep-
sequencing technologies will help further elucidate and iden-
tify the exact number of lncRNAs expressed during neuronal
development.
Of the 13,870 identiﬁed human lncRNAs, approximately one-
third are unique to the primate lineage (Derrien et al., 2012),
suggesting that ncRNA-dependent regulation of brain develop-
ment may have contributed to the evolution of higher cognitive
functions (Barry and Mattick, 2012; Barry, 2014). Consistent with
this idea, 47 of 49 conserved sequences across evolution displayed
sequence substitution rates statistically higher between human
and chimpanzees than rates compared to other sequences across
amniote evolution (Pollard et al., 2006). Of these human accel-
erated regions (HARs) that are non-coding, a quarter of these
mapped to locations adjacent to genes that regulate neural devel-
opment (Pollard et al., 2006). HAR1F, the most rapidly evolving
sequence of all, encodes a lncRNA that is prominently expressed in
the developing and adult brain. Although the function of HAR1F
is still unknown, this presents a tantalizing link between lncRNAs
and the formation of the proportionally larger and more complex
human brain (Pollard et al., 2006).
The large number of lncRNAs that display neuronal-speciﬁc
expression suggests an important role of lncRNAs in the neu-
ronal diversiﬁcation seen in higher vertebrates (Cao et al., 2006;
Amaral et al., 2008; Chodroff et al., 2010; Qureshi et al., 2010).
Additionally, the spatially and temporally restricted expression
patterns of many lncRNAs indicate that their expression is tightly
regulated, suggesting that lncRNAs may control the speciﬁca-
tion and function of individual neuronal subtypes (Mercer et al.,
2008). While functional characterization of neuronal-enriched
lncRNAs is still limited, broader studies of lncRNA function
have implicated lncRNAs as regulators of transcription through
both epigenetic regulations of chromatin structure and RNA-
transcription factor interactions. Here we focus on reviewing
recent advances in the identiﬁcation and functional analysis of
lncRNAs implicated in transcriptional regulation control of neural
development.
MECHANISMS OF lncRNA-DEPENDENT TRANSCRIPTIONAL
REGULATION
In general, lncRNAs function either in cis, within the same
genomic locus, or in trans, affecting gene transcription in a
different locus or even on different chromosomes. Many lncR-
NAs, including the intensely studied Xist and HOTAIR ncR-
NAs, function through recruitment of the Polycomb repressive
complex 2 (PRC2) by binding to PRC2 component histone-
lysine N-methyltransferase Ezh2, leading to a local increase in
H3K27me3 content and subsequent transcriptional repression
(Zhao et al., 2008, 2010; Tsai et al., 2010; Guil and Esteller,
2012). However, other lncRNAs, like the BORDERLINE lncRNA,
are shown to inhibit repressive histone modiﬁcations either
solely through their transcription or by binding to and remov-
ing the heterochromatin protein 1 (HP1/Swi6) from the locus
(Keller et al., 2013). The diverse functions observed for the
handful of characterized lncRNAs studied so far underscore
the importance of analyzing lncRNA function on an individual
basis.
NATURAL ANTISENSE TRANSCRIPTS
Natural antisense RNAs transcripts are lncRNAs that are tran-
scribed from the opposite strand (OS) of protein-coding genes,
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and therefore, share sequence complementarity. The degree of
complementarity of NATs with corresponding sense transcripts
varies greatly, however, genome-wide analysis suggests that local-
ization of antisense transcription is generally conﬁned to 250 bp
upstream of the sense transcript’s transcription start site and
1.5 kb downstream of the sense gene (Sun et al., 2005; Core
et al., 2008; Seila et al., 2008). As previously reviewed, NATs
mediate their function through transcriptional and epigenetic
regulation, RNA–DNA interactions, and RNA–RNA interactions
(Faghihi and Wahlestedt, 2009; Magistri et al., 2012). While
there are clear examples of antisense transcripts that directly
inhibit protein coding gene expression (Werner et al., 2014), the
inhibition is probably not mediated by complementary base-
pairing of sense–antisense transcripts. Since most lncRNAs are
expressed at much lower levels than neighboring protein-coding
genes, the stoichiometry between sense–antisense pairs is insuf-
ﬁcient to simply block splicing or translation of protein coding
genes.
One topic of particular current interest is the role of NATs that
work in conjunction with epigenetic modiﬁers. Many imprinted
genes are found in genomic clusters and have NATs located within
the same locus (Verona et al., 2003; Katayama et al., 2005; Wan and
Bartolomei, 2008; Mohammad et al., 2009). The imprinted locus
is facilitated through allele speciﬁc expression of NATs and corre-
sponding interactions with epigenetic modiﬁers. For example, the
NAT Air interacts with HMT G9a while Kcnq1ot1 interacts with
PRC2 components and HMT G9a (Nagano et al., 2008; Pandey
et al., 2008; Terranova et al., 2008). Through complementary
base pairing and RNA–protein interactions, the NAT transcript
allows sequence-speciﬁc recruitment of chromatin modiﬁers to
the locus. For both Air and Kcnq1ot1, NAT expression from the
paternal allele corresponds to paternal allele silencing through
chromatin condensation and bidirectional spreading of epige-
netic marks (Nagano et al., 2008; Kanduri, 2011). Epigenetic
control of protein coding genes by NATs is also observed in non-
imprinted loci. For example, brain-derived neurotrophic factor
(BDNF) is regulated by the NAT BDNF-AS. Loss of BDNF-
AS is accompanied by increased BDNF transcript abundance,
facilitated through an altered chromatin state (Modarresi et al.,
2012).
INTRONIC ncRNAs
While reports suggest that up to 35% of lncRNAs localize to
intronic sequences, little is known about the function of these
sequences (St Laurent et al., 2012). Surprisingly, intronic ncR-
NAs are predominantly associated with the sense strand of the
unprocessed mRNA, but often show expression patterns that are
inversely correlated with the processed mRNA (Katayama et al.,
2005; Nakaya et al., 2007; Dinger et al., 2008; Mercer et al., 2008).
This suggests a complex regulatory relationship in which intronic
ncRNA transcription may be independent of transcription of the
protein coding pre-mRNA. In some cases, these intronic ncR-
NAs are precursor transcripts to miRNAs. Recent work has also
suggested that many intron-derived RNAs bind to Ezh2 of the
PRC2 complex, thus recruiting chromatin structure modiﬁers to
the locus to silence transcription (Guil and Esteller, 2012; Guil
et al., 2012).
NON-CODING OPPOSITE-STRAND TRANSCRIPTS (ncOSTs),
PROMOTER-ASSOCIATED lncRNAs,
ENHANCER-ASSOCIATED RNAs (eRNAs), ULTRACONSERVED
ELEMENT-ASSOCIATED lncRNAs, AND CIRCULAR RNAs
Some lncRNAs are transcribed from the proximal promoters in the
opposite direction of protein coding genes, and have been termed
“opposite strand” transcripts. Conservative estimates suggest that
one-third of brain-enriched transcription factors express corre-
sponding OS transcripts and that many of these may act in cis
to regulate protein-coding gene transcription (Alfano et al., 2005;
Rapicavoli et al., 2010). Many OS transcripts display correlated
expression patterns with neighboring protein-coding genes as a
result of bi-directional promoters initiating transcription of both
the lncRNA and protein-coding gene (Uesaka et al., 2014). Recent
reports analyzing the function of Six3OS and Vax2OS, however,
indicate that some OS transcripts function in trans, and not by
regulating expression of their neighboring protein-coding gene
(Rapicavoli et al., 2011; Meola et al., 2012).
Other promoter-associated lncRNAs overlap proximal pro-
moter sequences but are transcribed from the sense strand relative
to the protein-coding gene. The transcription of the lncRNA itself
can positively impact transcription in cis of the protein-coding
gene, by changing chromatin conformation to permit transcrip-
tion factor recruitment, leading to initiation of protein-coding
gene transcription. Alternatively, promoter-associated lncRNAs
can inhibit protein-coding gene transcription through one of
two different proposed mechanisms. Chromatin de-condensation
that occurs as a result of transcription of a lncRNA within the
promoter region of a protein-coding gene may inhibit transcrip-
tion of nearby genes by altering DNA supercoiling. Conversely, it
was recently shown that transcription of the CCND1 promoter-
associated lncRNA (CCND1-pncRNA) recruits the TLS protein
to the promoter of CCND1 during DNA damage. The recruit-
ment of TLS reduces transcription of CCND1 by inhibiting the
histone acetyltransferase activity of CBP/p300 at the gene’s pro-
moter (Wang et al., 2008; Kurokawa, 2011). This further suggests
that some promoter-associated lncRNAs may regulate transcrip-
tion of neighboring protein-coding genes through recruitment of
chromatin-modifying complexes.
Past efforts in comparative genetics have identiﬁed thousands
of sequences that display high sequence constraints across evolu-
tion (Bejerano et al., 2004; Woolfe et al., 2005; Pennacchio et al.,
2006). These ultra-conserved regions (UCRs) identiﬁed fromFugu
rubripes and human (Woolfe et al., 2005; Pennacchio et al., 2006)
or human, mouse, and rat (Bejerano et al., 2004) are at least
200 bp and display>90% sequence conservation. The UCRs tend
to cluster around genes pertinent to the regulation of organism
development. Therefore, the preferential localization and high-
degree of sequence conservation has led to the hypothesis that
these UCRs are vital to the regulation of development. Fur-
ther studies analyzing these sequences have identiﬁed that many
function as enhancer sequences (Woolfe et al., 2005; Pennacchio
et al., 2006). However, in these studies, many UCRs also over-
lapped known expressed sequence tag (EST) transcripts that were
rationalized as genomic contamination or incompletely spliced
pre-mRNA (Bejerano et al., 2004; Woolfe et al., 2005). Roughly
240 (50%) and 84 UCRs (6%) showed evidence for transcription
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in the Bejerano et al. (2004) and Woolfe et al. (2005) studies,
respectively. Additional work on UCRs has since conﬁrmed that
these enhancers/UCRs can indeed be transcribed into non-coding
sequence.
The discovery that many enhancers or ultra-conserved ele-
ments are not only platforms for transcription factor binding
but also are transcribed themselves has stimulated studies of the
role played by eRNA transcription in the regulation of neighbor-
ing genes (De Santa et al., 2010; Kim et al., 2010; Licastro et al.,
2010; Wang et al., 2011). Most eRNAs are short sequences, result-
ing from bi-directional transcription of enhancer sequences. They
exhibit H3K4me1-enriched sequences and lack poly-adenylation
signals. One proposed mechanism of eRNA function in tran-
scriptional regulation is a ripple effect, a process where growth
factor-induced immediate-early gene transcription triggers initi-
ation of transcription at nearby promoters (Ebisuya et al., 2008).
One could postulate that eRNAs may function in a similar man-
ner, with transcription factors binding to enhancers, recruiting the
transcriptional machinery to the enhancer to induce eRNA tran-
scription and chromatin modiﬁcations, leading to activation of
neighboring genes. To date, however, no evidence is available to
suggest such a mechanism exists for eRNA-dependent regulation
of transcription. The expression of eRNAs generally correlates
with activation of the neighboring gene(s; Lee, 2012; Li et al.,
2013b; Melo et al., 2013; Memczak et al., 2013).
Examples exist, however, in which lncRNA sequence overlaps
the ultraconserved enhancer sequence of neighboring genes (Feng
et al., 2006). Transcription of lncRNA sequences from ultracon-
served sequences, in sharp contrast to eRNAs, may actually inhibit
antisense gene transcription of neighboring targets (Bond et al.,
2009). Analyses of lncRNAs that overlap ultraconserved element
sequences have been shown to possess characteristics more sim-
ilar to lincRNAs, and therefore, are not typically classiﬁed as
eRNAs. These signatures include H3K4me3 and modiﬁcation
by 3′-polyadenylation. Although many of the transcribed ultra
conserved elements overlap known enhancer sequences; only a
minority (∼4%) are transcribed bi-directionally and are unlikely
to encode short RNAs (Licastro et al., 2010). Together, this pro-
vides further indication that these lncRNAs are more similar
to lincRNAs than eRNAs. One possible mechanism of func-
tion for lncRNAs that overlap ultraconserved enhancer regions
comes from recent studies of the lncRNA CCATT1-L. CCATT1-L
is expressed from a super enhancer region 515 kb upstream of the
MYC locus and positively regulatesMYC transcription by facilitat-
ing chromatin interactions between the MYC proximal promoter
and enhancer elements (Xiang et al., 2014). This suggests that
lncRNAs may facilitate transcription factor recruitment to spe-
ciﬁc DNA sequences, a potential mechanism discussed in further
detail below.
Circular RNAs (circRNA) deﬁne a more unconventional and
less well understood class of functional ncRNAs. These unique
transcripts were originally identiﬁed in plants where they function
to encode subviral components (Sanger et al., 1976). In animal
species, these transcripts are thought to arise from joining of
5′ and 3′ splice sites within a single exon to form the circular
transcript (Nigro et al., 1991; Capel et al., 1993; Cocquerelle et al.,
1993; Chao et al., 1998; Burd et al., 2010; Hansen et al., 2011;
Salzman et al., 2012). Recent proﬁling of mouse, human, and
Caenorhabditis elegans identiﬁed thousands of conserved circR-
NAs (Memczak et al., 2013). The identiﬁed circRNAs are often
highly conserved, leading the authors to hypothesize that the cir-
cRNA transcripts function as molecular decoys for RNA-binding
proteins and miRNAs (Memczak et al., 2013).
LincRNAs
Other lncRNAs do not overlap with either protein coding genes
or promoter or enhancer sequences. These are collectively termed
long intergenic ncRNAs (lincRNAs). Analyses of the correlated
expression patterns of lincRNA and transcripts of neighboring
protein-coding genes imply that lincRNAs participate in sim-
ilar biological processes to neighboring protein-coding genes
(Luo et al., 2013). This has been interpreted that many lincR-
NAs may function in cis to regulate expression of nearby genes
(Luo et al., 2013). However, this ﬁnding also raises the possi-
bility that lincRNAs might act in trans to directly or indirectly
regulate the activity of co-expressed protein coding genes through
RNA–protein interactions.
One classical example of lincRNA function comes from stud-
ies of HOTAIR. HOTAIR is transcribed from an intergenic region
in the HOXC locus and is involved in recruitment of chromatin
modiﬁers to hundreds of genomic loci (Rinn et al., 2007; Tsai
et al., 2010; Chu et al., 2011). Through interactions with the PRC2
and LSD1 complexes, HOTAIR promotes H2K27 methylation and
H3K4 demethylation, respectively, resulting in the leading to gene
silencing (Rinn et al., 2007; Tsai et al., 2010; Chu et al., 2011). More
speciﬁcally, HOTAIR expression silences expression of genes from
the HOXD locus, thereby facilitating HOXC locus gene expres-
sion specifying positional identity of the HOTAIR-expressing cells
(Rinn et al., 2007). Knockout of Hotair in mice causes skeletal
defects including homeotic transformation of vertebrae result-
ing from de-repression of multiple HoxD cluster genes, increased
expression of ∼30 genes from imprinted loci and loss of vertebral
boundary speciﬁcation during development (Li et al., 2013a).
COMMON FUNCTIONAL PROPERTIES OF
lncRNA-DEPENDENT TRANSCRIPTIONAL REGULATION
As previously stated, many lncRNAs have been proposed to func-
tion through interactions with chromatin modiﬁers. In fact, it
is estimated that ∼30% of all lincRNAs expressed in mouse
ES cells interact with one or more of 11 particular chromatin
modiﬁers (Khalil et al., 2009; Guttman et al., 2011). This has
been extrapolated to suggest that interaction with chromatin
regulators is the major mechanism by which lncRNAs regulate
transcription. However, many of these lncRNAs display predom-
inantly cytoplasmic expression, suggesting instead that they may
have additional cellular functions. Furthermore, there is reason
to suspect that the selectivity of lncRNA–chromatin modiﬁer
interactions may have been overestimated. Experiments using
overexpressed, tagged lncRNAs followed by mass spectrometry
do not take into account the low transcript abundance levels seen
for most lncRNAs. Chromatin-modifying enzymes are likewise
abundantly expressed in virtually all cell types, particularly in
comparison to transcription factors. It is thus possible that weak
and possibly non-physiological interactions between lncRNAs and
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chromatin-modifying proteins may be detected using mass spec-
trometry. This may include weak interactions of highly expressed
proteins that have known RNA binding potential, such as PRC2
complex proteins. Furthermore, recent reports suggest that the
PRC2 protein complex is quite promiscuous in its RNA binding
speciﬁcity (Davidovich et al., 2013). A more systematic interro-
gation of potential lncRNA–protein interactions using techniques
that control for the abundance of both lncRNA and protein, such
as protein microarrays, will help clarify this issue.
LncRNAs AS MOLECULAR SCAFFOLDS FOR ORGANIZING
TRANSCRIPTION AND SIGNALING
The characterization individual lncRNAs suggest that lncRNAs
may function to serve as molecular scaffolds (Figure 2). Aptamer
selection experiments reveal that it is relatively easy to evolve RNAs
that show moderate binding afﬁnity to a broad range of substrates,
including proteins and small molecules, and demonstrate that
aptamer–protein interactions show far less constraint at the level
of primary sequence than do protein–protein interactions (Wil-
son and Szostak, 1999; Kang and Lee, 2013). In combination with
homologous Watson–Crick base pairing, which provides a ready
means by which RNA can selectively interact with other nucleic
acid targets, this allows lncRNAs to act as molecular hubs that
facilitate assembly of macromolecular complexes that can include
proteins, DNA, and other RNAs.
If secondary structure primarily underlies lncRNA–protein
interactions, as implied by aptamer studies, conventional sequence
alignment software may not be optimal for identifying func-
tional lncRNAs. Indeed, recent reports suggest that >20% of
the human RNAs display evolutionarily conserved secondary
structures independent of primary sequences (Smith et al., 2013).
Reports analyzing interactions of the lncRNA Xist, RepA, or other
FIGURE 2 | LncRNA regulation of transcription and translation by
acting as scaffolds to facilitate interactions between
macromolecules. Schematic examples of how lncRNAs participate in
RNA–DNA, RNA–RNA, and RNA–protein interactions to facilitate the
regulated expression of protein coding genes. (A) LncRNAs like Six3OS
interact with chromatin-modifying complexes to regulate gene
transcription. Additionally, lncRNAs can interact with transcription factors
to facilitate target gene expression. (B) Complementary sequence on
lncRNAs with enhancer sequences is proposed to enable chromatin
looping to regulate gene transcription. (C) Expression of lncRNAs that
contain repeat sequences for protein binding help facilitate co-regulated
transcription of multiple targets, including transcription across different
chromosomes. (D) LncRNAs are implicated in the formation and
maintenance of nuclear paraspeckles that facilitate alternative splicing
events of nascent transcripts. (E) Through homologous base-pairing with
mRNA transcripts and interactions with ribosomal proteins and/or RNAs,
lncRNAs are able to target mRNAs to the ribosomes. (F) Containing
complementary target sequences, lncRNAs also serve as miRNA
decoys to prevent interactions of miRNAs with protein-coding
transcripts.
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short ncRNAs suggest that a double stem–loop structure is sufﬁ-
cient for PRC2 binding (Zhao et al., 2008; Kanhere et al., 2010).
The presence of short repeats within lncRNAs that display con-
served secondary structure can then facilitate protein recruitment
to the regions where the lncRNA is localized. This has been
recently exempliﬁed by the lncRNA Firre, which contains repeat
domains for nuclear matrix factor hnRNPU binding (Hacisuley-
man et al., 2014). In serving as a scaffold, Firre is thought to
mediate intra-chromosomal bridging and focalized transcription
of Firre-regulated targets (Hacisuleyman et al., 2014).
Further evidence of lncRNAs serving as molecular scaffolds
comes from studies analyzing lncRNA co-localization with the
nuclear paraspeckles, domains that are thought to be locations
of retained RNAs where alternative splicing events are regulated
(reviewed in Spector and Lamond, 2011). The highly expressed
nuclear lncRNAs Neat1 and Malat1 both localize to these nuclear
subdomains (Clemson et al., 2009; Tripathi et al., 2010). The
paraspeckle domains are thought to be locations of retained
RNAs where alternative splicing events are regulated (reviewed
in Spector and Lamond, 2011). Neat1 induces paraspeckle for-
mation and Malat1 recruits splicing factors to these domains
(Clemson et al., 2009; Tripathi et al., 2010). Through both RNA–
RNA interactions and RNA–protein interactions, these lncRNAs
are thus implicated in regulating splicing.
Analysis of the lncRNA Hotair suggests that lncRNAs can also
regulate post-transcriptional processes. Hotair associates with the
RNA-binding and ubiquitin ligase proteins Dzip3 and Mex3b
(Yoon et al., 2013). Additionally, Hotair binds the ubiquitin ligase
substrates Ataxin-1 and Snurportin-1, thereby facilitating inter-
action of the proteins and ubiquitin-dependent degradation of
Ataxin-1 and Snurportin-1 (Yoon et al., 2013). Additional studies
like these are required to address the functions of the multitude
of lncRNAs that are expressed in the cytoplasm and that do not
directly regulate chromatin modiﬁcations and gene transcription
(van Heesch et al., 2014).
LncRNAs IN THE DEVELOPING NERVOUS SYSTEM
Transcript expression analyses within the nervous system have
shown an abundance of lncRNAs that display spatially restricted
and temporally dynamic expression (Blackshaw et al., 2004;
Mehler and Mattick, 2007; Mercer et al., 2008; Aprea et al., 2013;
Luo et al., 2013; Lv et al., 2013). In fact, lncRNAs generally dis-
play more tissue speciﬁcity than protein-coding genes (Luo et al.,
2013). The spatial and temporal regulation of lncRNAs is therefore
hypothesized to promote neuronal diversiﬁcation and speciﬁca-
tion. Indeed, comparative analyses of sequences from human
and chimpanzee brains identiﬁed non-coding HARs that dis-
play fast evolution and are correlated with human-speciﬁc brain
functions (Pollard et al., 2006). The HARs and many other lncR-
NAs display preferential genomic localization near protein-coding
genes involved in neurodevelopment and are proposed to func-
tion through cis-regulation of the locus (Dinger et al., 2008; Luo
et al., 2013), further implicating the requirement of lncRNA func-
tion in neurodevelopment. In addition, biological signiﬁcance of
lncRNAs in the developing nervous system is beginning to be
understood through both loss- and gain-of-function experiments
analyzing individual lncRNAs. Information regarding the iden-
tity and function of lncRNAs expressed in the developing central
nervous system (CNS) is summarized in Table 1.
INSIGHTS FROM CONTROLLED DIFFERENTIATION OF ES CELLS
Recent studies have focused on the identiﬁcation of lncRNAs
expressed during neuronal differentiation, either in stem cells
or in vivo. The rationale behind these studies suggests that the
identiﬁcation of lncRNAs that display dynamic expression across
developmental stages can be extrapolated to lncRNA participation
in differentiation. For example, expression proﬁling of embryoid
body (EB) differentiation of mouse embryonic stem cells (ES)
revealed 174 lncRNAs that displayed differential expression pat-
terns (Dinger et al., 2008). Consistent with previous reports on
protein-coding gene expression in pluripotent cells (Ivanova et al.,
2002; Ramalho-Santos et al., 2002; Bruce et al., 2007; Dinger et al.,
2008), twice as many lncRNAs were expressed during pluripo-
tent stages versus more committed lineages (Dinger et al., 2008).
Overall, 12, 7, and 31 lncRNAs displayed dynamic expression
patterns consistent with pluripotency, primitive streak forma-
tion/gastrulation and hematopoiesis, respectively, with many
lncRNAs displaying expression patterns with positive correla-
tions to neighboring protein-coding genes (Dinger et al., 2008).
Further reports have identiﬁed 226 lncRNAs expressed in pluripo-
tent ES cells (Guttman et al., 2009, 2010), 137 of which were
knocked-down and showed a signiﬁcant impact on ES cell gene
expression (Guttman et al., 2011). Importantly, loss-of-function
studies indicated that 26 of these lncRNAs function to maintain
ES cell pluripotency (Guttman et al., 2011). In both studies, many
identiﬁed lncRNAs were proposed to regulate gene transcrip-
tion through identiﬁed RNA–protein interactions of lncRNA and
protein components of chromatin-modifying complexes (Dinger
et al., 2008; Guttman et al., 2011). The importance of lncRNAs in
pluripotency was further conﬁrmed through observations where
two lncRNAs, themselves transcriptional targets of Oct4 and
Nanog, regulate pluripotency through a feedback-loop regulat-
ing Oct4 and Nanog transcript expression (Sheik Mohamed et al.,
2010).
Additional studies have more speciﬁcally characterized the
requirement of lncRNAs in neural and oligodendrocyte induc-
tion (Mercer et al., 2010; Ng et al., 2012). In comparing neural
progenitor cells differentiated from human ES cells, Ng et al.
(2012) observed 934 of 6671 lncRNAs that displayed differen-
tial expression by microarray analysis. Similar to previous reports
in mouse ES cells, 36 lncRNAs displayed expression patterns
consistent with regulation of pluripotency, three of which were
experimentally shown to regulate pluripotency through knock-
down studies and contained OCT4- and NANOG-binding sites in
their proximal promoter. Further characterization through RNA
immunoprecipitation (RIP) indicated that two lncRNAs inter-
acted directly with the pluripotency transcription factor SOX2
and the PRC2 chromatin-modifying complex component SUZ12
(Ng et al., 2012). In these studies, 35 lncRNAs displayed expression
patterns consistent with a role in neural induction, four of which
were studied and shown to be required for proper neural differ-
entiation. Of these four lncRNAs, one (AK055040) was shown
to interact with SUZ12, indicating a functional role in chromatin
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Table 1 | LncRNAs in neurodevelopment and neurodevelopmental disorders.
lncRNA Classification Function References
AK055040 Promoter-associated Located upstream of CACN2D1; interacts with SUZ12 and is required for
neural induction of ES cells
Ng et al. (2012)
AK091713 Overlapping Contains miRNAs Mir125B and LET7A and the nuclear encoded mitochondrial
protein BLID within its introns; required for neural induction of ES cells by
regulated expression of miRNAs that promote neurogenesis
Ng et al. (2012)
AK124684 lincRNA Interacts with the master negative regulator of neurogenesis, REST; required
for neural induction of ES cells
Ng et al. (2012)
ANRIL/
CDKN2B-AS
Antisense CDKN2B located on the opposite strand within ANRIL intron1; binds
chromatin-modifying complexes to regulate CDKN2A/B expression; mutations
in promoter and transcript sequence correlate with multiple genetic disorders
Yap et al. (2010), Aguilo et al.
(2011), Kotake et al. (2011),
Pasmant et al. (2011a,b),
Congrains et al. (2013)
BACE1-AS NAT Positive regulator of BACE1 expression; increased expression correlates with
Alzheimer’s disease pathology
Faghihi et al. (2008),
Modarresi et al. (2011)
BDNF-AS NAT Negative regulation of BDNF through recruitment of chromatin-modifying
complex to BDNF locus
Modarresi et al. (2012)
CDRas1 circRNA miR-7 decoy; over-expression results in the reduced size of the zebraﬁsh
midbrain, similar to miR-7 loss-of-function
Memczak et al. (2013)
Cyrano lincRNA Loss of function results in small eyes and brains due to a reduction in neural
speciﬁcation; may function as a miR-7 decoy transcript
Ulitsky et al. (2011)
Dlx1AS Enhancer-associated
and NAT
Overlaps conserved enhancer between Dlx1/2; inhibits Dlx1 expression; loss
causes increased interneuron number; required for neuronal differentiation of
ES cells
Dinger et al. (2008), Mercer
et al. (2010), Kraus et al. (2013)
Evf2/Dlx6AS Enhancer-associated Overlaps conserved enhancer between Dlx5/6; recruits Dlx1/2 and MECP2 to
Dlx5/6 enhancer to control GABAergic interneuron speciﬁcation; loss causes
reduced GABAergic neuron number and reduced inhibition of CA1 pyramidal
neurons
Feng et al. (2006), Bond et al.
(2009), Berghoff et al. (2013)
GDNF-OS Promoter-associated
opposite strand
Negative regulation of GDNF Airavaara et al. (2011),
Modarresi et al. (2012)
Gomafu/
Miat/RNCR2
lincRNA Interacts with splicing factors to regulate alternative splicing; inhibits amacrine
cell speciﬁcation; associated in GWAS studies with eye movement disorders
in schizophrenia; down-regulated in schizophrenic brains
Takahashi et al. (2003),
Rapicavoli et al. (2010), Tsuiji
et al. (2011), Barry et al. (2013)
Kcna2AS NAT Inhibits expression of Kcna2; results in decreased voltage-gated potassium
currents and increased resting membrane potential leading to pain
hypersensitivity
Zhao et al. (2013)
Linc-Brn1b lincRNA Loss causes reduced Brn1 expression, reduced proliferation of intermediate
progenitors in the SVZ of the dorsal telencephalon and fewer upper layer
cortical neurons
Sauvageau et al. (2013)
Linc00299 lincRNA Deletion/interruption results in cognitive developmental delay in humans
caused by improper neural development
Talkowski et al. (2012)
Malat1 lincRNA Regulation of alternative splicing through recruitment of slicing factors to
paraspeckles; regulation of synaptogenesis through gene splicing;
cis-regulation of gene expression
Bernard et al. (2010), Tripathi
et al. (2010), Zong et al. (2011),
Zhang et al. (2012)
Megamind lincRNA Loss of function results in small eyes and brains due to a reduction in neural
speciﬁcation
Ulitsky et al. (2011)
Neat1 lincRNA Induction of paraspeckle formation Clemson et al. (2009)
(Continued)
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Table 1 | Continued
lncRNA Classification Function References
Paupar lincRNA; Promoter-
associated?
Negative regulation of Pax6 expression; regulation of Pax6 target gene (and
others) expression through occupancy of promoter sequences
Vance et al. (2014)
RMST lincRNA Binds to Sox2 and the promoters of Sox2 targets to facilitate Sox2-dependent
neural induction
Ng et al. (2012, 2013)
Six3OS Promoter-associated
opposite strand
Regulation of Six3 targets through interactions with Eya proteins and the
chromatin-modifying protein Ezh2; required for neural speciﬁcation of ES cells
Alfano et al. (2005), Zhao et al.
(2010), Rapicavoli et al. (2011)
Sox2dot Enhancer-associated Overlaps a distal enhancer of Sox2; expressed in neurogenic regions of the
brain
Amaral et al. (2009)
Tug1 lincRNA Up-regulated in response to taurine; inhibition of cone photoreceptor
speciﬁcation through PRC2 complex-mediated chromatin modiﬁcations
affecting cell-cycle regulation
Altshuler et al. (1993), Young
et al. (2005), Khalil et al. (2009)
TUNA lincRNA Regulates pluripotency by recruiting RNA biding proteins to Sox2, Nanog, and
Fgf4 promoters; required for neural speciﬁcation of ES cells
Lin et al. (2014)
utNgn1 Enhancer-associated Located ∼6 kb upstream of Neurog1 gene; required for proper Neurog1
transcription and mouse cortical progenitor differentiation
Onoguchi et al. (2012)
Vax2OS Promoter-associated
opposite strand
Maintenance of proliferation through alterations to cell cycle progression in
neural progenitors
Meola et al. (2012)
modiﬁcations in the regulation of neurogenesis. An additional
lncRNA (AK124684) was found to interact with the transcrip-
tional factor REST (Ng et al., 2012), a master negative regulator of
neurogenesis that binds to the promoters of neurogenic genes to
inhibit gene transcription (Ballas et al., 2005; Abrajano et al., 2009;
Gao et al., 2011). A third lncRNA (AK091713) was subsequently
shown to contain miRNAs miR-125b and let-7a within its intronic
sequence, thereby driving neurogenesis through the expression
of neurogenic miRNAs (Rybak et al., 2008; Le et al., 2009; Ng
et al., 2012). Other studies identiﬁed that the lncRNAs Six3OS
and Dlx1AS are required for directed differentiation of pluripo-
tent stem cells towards a neuronal precursor identity (Ramos et al.,
2013).
Among lncRNAs found to regulate neurogenesis, the lincRNA
RMST was targeted for additional follow-up studies. RMST in
humans is located ∼150 kb away from the closest annotated
protein-coding gene (Ng et al., 2012). The promoter of RMST
contains REST binding sites and is occupied by REST, suggesting
that RMST is activated during neurogenesis through dissocia-
tion of REST from the promoter (Ng et al., 2013). Analysis of
RMST revealed that RMST promotes neurogenesis through inhi-
bition of glial fates (Ng et al., 2013). RNA pull-down experiments
indicated that RMST interacts with the RNA binding protein
hnRNPA2/B1 and SOX2, both of which are also required for neu-
ronal differentiation (Ng et al., 2013). Ultimately, it was observed
that RMST regulates neuronal differentiation through directing
SOX2 to the promoter of neurogenic transcription factors, to pro-
moteneurogenic gene expression andneural fate commitment (Ng
et al., 2013). RMST does not bind REST or the PRC2 chromatin-
modifying complex protein SUZ12 (Ng et al., 2012). Using both
RIP and chromatin isolation by RNA puriﬁcation (ChiRP) to
identify DNA-binding sites of lncRNAs (Chu et al., 2011), the
researchers provided evidence that RMST binds to promoters of
Sox2 target genes, and activates transcription of these genes by
recruiting Sox2 (Ng et al., 2013). The mechanism by which RMST
is recruited to Sox2 consensus binding sites is unclear, but is pos-
tulated to occur through homologous base pairing that leads to
the formation of RNA–DNA hybrids (Ng et al., 2013). If this is the
case, this may turn out to be a more general mechanism by which
trans-acting lncRNAs regulate gene expression.
Similar to RMST, utNgn1, and Sox2dot display expression
proﬁles that positively correlate with differentiation of neural pro-
genitors (Amaral et al., 2009; Onoguchi et al., 2012). Importantly,
both of these lncRNAs overlap sequences of ultra conserved ele-
ments implicated in neuronal development (Amaral et al., 2009;
Onoguchi et al., 2012). UtNgn1 is required for Neurogenin1 (Neu-
rog1) transcription and PRC2-mediated repressive signals at the
utNgn1 locus are associated with both decreases in utNgn1 and
Neurog1 transcript abundance (Onoguchi et al., 2012). Inhibition
of utNgn1 expression during mouse cortical progenitor differen-
tiation resulted in decreased expression of neurogenic markers,
consistent with a role of utNgn1 in promoting neurogenesis
through activation of Neurog1 transcription (Onoguchi et al.,
2012). The exact mechanism by which transcription of utNgn1
at the Neurog1 enhancer mediates Neurog1 transcription remains
elusive. Similarly, expression of Sox2dot in the neurogenic regions
of the brain suggests that it functions to regulate neural devel-
opment (Amaral et al., 2009). The function of Sox2dot in neural
development remains to be investigated.
More recent experiments have identiﬁed 20 additional lncR-
NAs that regulate pluripotency. In particular, the lncRNA TUNA,
was shown to be highly conserved among vertebrates and was
expressed within the developing nervous system (Lin et al.,
2014). TUNA was shown to regulate pluripotency through the
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binding of three RNA binding proteins and co-occupancy of the
RNA–protein complex at the promoters of Sox2, Nanog, and Fgf4.
Inhibition of TUNA resulted in the decreased capacity of mESCs to
differentiate to neural lineages (Lin et al., 2014). Consistent with a
role in regulating neural development, TUNA expression is corre-
lated with Huntington’s disease (HD) prognosis, and inhibition of
TUNA in zebraﬁsh results in locomotor defects (Lin et al., 2014).
CONTROL OF NEURAL DEVELOPMENT IN VIVO BY LncRNAs
LncRNAs in retinal development
While the identiﬁcation and validation of the function of lncR-
NAs during neuroectodermal differentiation from cultured ES
cells have provided a wealth of information regarding which lncR-
NAs to target, relatively few studies have begun to examine the role
of individual lncRNAs in vivo during neurodevelopment. To date,
many examples of lncRNA function in vivo come from studies ana-
lyzing the role of ncRNAs during retinal development (reviewed
in Rapicavoli and Blackshaw, 2009). Speciﬁcally, four lncRNAs
have been implicated in regulating cell fate decisions during reti-
nal development. Tug1 was identiﬁed in a screen to characterize
genes that display enhanced expression in response to taurine,
which promotes rodphotoreceptor differentiation (Altshuler et al.,
1993;Young et al., 2005). Tug1 knock-down experiments displayed
abnormal morphology of inner and outer segments of photore-
ceptors, accompanied by increased cell death and an increase
in the percentage of electroporated cells expressing the cone-
photoreceptormarker peanut agglutinin (PNA;Young et al., 2005).
Studies analyzing the interactions of lincRNAs with chromatin-
modifying complexes identiﬁed an association betweenTUG1 and
the PRC2 complex (Khalil et al., 2009). Further characterization
of Tug1 revealed that it is activated in a p53-dependent man-
ner, and loss of Tug1 results in the up-regulation of ∼120 genes,
most of which are genes involved in cell-cycle regulation (Guttman
et al., 2009; Khalil et al., 2009). Combined, these results indicated
that Tug1 functions to promote rod genesis through inhibition of
cone photoreceptor cell fate through its interactionswith repressed
chromatin (Young et al., 2005; Khalil et al., 2009). However, only a
subset of cellular Tug1 RNA is localized to the nucleus, suggesting
that other mechanisms of TUG1 function may exist (Khalil et al.,
2009).
The lncRNAVax2os has been shown to display predominately
retinal expression, speciﬁcally at post-natal periods during mouse
development (Alfano et al., 2005). Vax2os1 was also found to reg-
ulate mouse photoreceptor differentiation (Meola et al., 2012).
Vax2os1 is endogenously expressed in the ventral retina of mice,
primarily localizing to the outer neuroblastic layer of the develop-
ing retina. Overexpression of Vax2os1 increases the proportions
of proliferating cells in the dorsal retina (low endogenous expres-
sion of Vax2os1) through perturbation of cell cycle progression in
neural progenitors (Meola et al., 2012). The increase in prolifera-
tive progenitors and increased apoptosis inVax2os1 overexpressing
cells resulted in a decrease of photoreceptor differentiation (Meola
et al., 2012).
The lncOST Six3os is co-expressed with the homeodomain
transcription factor Six3 in retinal progenitor cells (Blackshaw
et al., 2004). Six3os is juxtaposed to Six3 and transcribed in the
opposite direction of Six3 in both mouse and human (Alfano
et al., 2005; Rapicavoli et al., 2011). Six3os, however, does not
regulate Six3 transcription. The Six3os transcript forms an RNA–
protein complex with transcriptional co-regulators of Six3 such
as Eya1, but not with Six3 itself, suggesting that Six3os controls
expression of Six3 target genes (Alfano et al., 2005; Rapicavoli
et al., 2011). Furthermore, Six3os interacts with the Ezh2 com-
ponent of the PRC2 complex (Zhao et al., 2010; Rapicavoli et al.,
2011), suggesting that Six3os may function to repress Six3 targets
by triggering H3K27me3 modiﬁcation. This is further supported
by experiments in which Six3os overexpression blocked changes in
retinal cell fate induced by Six3 overexpression (Rapicavoli et al.,
2011). Inhibition of Six3os expression resulted in a decrease in
rod bipolar cells with a concomitant increase in Müller glial cell
number (Rapicavoli et al., 2011). This phenotype is similar to loss
of function of Six3 alone (Zhu et al., 2002; Rapicavoli et al., 2011).
Another lncRNA that is also prominently expressed in the
retina and has recently been functionally characterized is Gomafu
(also known as RNCR2 and Miat). Gomafu is one of the most
abundant polyadenylated RNAs found in the neonatal retina
(Blackshaw et al., 2004), and is expressed widely throughout
the nervous system, displaying nuclear localization to a novel
nuclear domain within neural precursors (Ishii et al., 2006; Sone
et al., 2007; Chen and Carmichael, 2010). Overexpression of
Gomafu in the developing retina had no effect on retinal devel-
opment, presumably due to the already high abundance levels
of Gomafu transcript (Rapicavoli et al., 2010). Inhibition of
Gomafu expression/function resulted in an increase in amacrine
and Müller glial cells in the developing retina, suggesting that
Gomafu negatively regulates amacrine cell fate speciﬁcation and
delays Müller glial cell speciﬁcation (Rapicavoli et al., 2010).
Additional studies on Gomafu revealed that it selectively bound
splicing regulators such as SF1 and Qk, and that its loss of
function disrupted splicing of a subset of neuronal pre-mRNAs
(Tsuiji et al., 2011; Barry et al., 2013). However, the mechanism
by which Gomafu-dependent mRNA splicing affects amacrine
and Müller glial cell speciﬁcation remains elusive. Since many
other lncRNAs are prominently expressed in the developing
retina (Blackshaw et al., 2004), further studies will undoubtedly
identify further instances in which lncRNAs regulate the expres-
sion and/or activity of protein-coding genes essential for retinal
development.
LncRNAs that regulate development of other CNS regions
Although the study of lncRNAs in other regions of the developing
CNS has lagged behind studies in retina until recently, this is now
rapidly changing. At least a half-dozen lncRNAs have now been
functionally characterized in developing brain. Several examples
of functional lncRNAs have been identiﬁed through analysis of the
transcriptional control of GABAergic interneuron speciﬁcation.
During development, multipotent progenitors that give rise to
both GABAergic interneurons and oligodendrocytes are generated
from the medial and caudal ganglionic eminences of the ventral
telencephalon (Anderson et al., 1997; Panganiban and Rubenstein,
2002; Yung et al., 2002). In vitro differentiation of embryonic
forebrain-derived neural stem cells identiﬁed a host of additional
lncRNAs dynamically expressed during GABAergic interneuron
speciﬁcation (Mercer et al., 2010), including two lncRNAs that
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overlap ultraconserved enhancers of the DLX family of proteins,
Dlx1AS and Evf2.
Evf2 is partially transcribed from an ultra-conserved enhancer
sequence (ei) located between the convergently transcribed Dlx5
and Dlx6 genes (Feng et al., 2006). Evf2 is transcribed in the anti-
sense direction to Dlx6, with the entire sequence for Dlx6 localized
within intron 2 of Evf2 (Feng et al., 2006). Transcription of Evf2
results in the recruitment of Dlx1/2 and MECP2 transcription fac-
tors to theDlx5/6 enhancers to regulateDlx5/6 transcription (Feng
et al., 2006; Bond et al., 2009). Loss of Evf2 results in an increase
in Dlx6 transcript abundance, a phenotype that cannot be rescued
with Evf2 overexpression, suggesting that transcription of Evf2
inhibits activation of Dlx6 transcription in cis through opposite-
strand inhibition (Bond et al., 2009). Further studies indicate that
Evf2 trans activity inhibits the ei enhancer methylation (Berghoff
et al., 2013). Altogether, Evf2 functions in both cis and trans to
regulate transcription of Dlx5/6 and chromatin status of the ei
ultra-conserved enhancer.
Dlx1AS is localized in the Dlx1/2 locus similar to Evf2 in the
Dlx5/6 locus, such that Dlx1AS overlaps the conserved enhancer
between the convergently transcribed Dlx1/2 genes (Dinger et al.,
2008). In contrast to the genomic architecture of Evf2, exon 2 of
Dlx1AS overlaps the Dlx1 coding sequence in the antisense orien-
tation, suggestingDlx1AS may also function as a NAT (Kraus et al.,
2013). Genetic loss of Dlx1AS results in increased Dlx1 expression,
suggesting a negative regulation of Dlx1 by Dlx1AS, potentially
through antisense inhibition (Kraus et al., 2013). These reports
suggest that lncRNAs transcribed from ultra conserved sequences
can function through molecular mechanisms shared with other
classes of lncRNAs. They may also control activity and/or recruit-
ment of transcription factors at enhancers throughdosageor allelic
differences in lncRNA abundance, adding an additional layer of
complexity to enhancer-mediated gene regulation (Amaral et al.,
2009).
In order to study loss of function of Dlx1AS and Evf2 in vivo,
homologous recombination was used to insert premature poly-
adenylation sequences in both lncRNAs, as genomic deletion of
either Dlx1AS or Evf2 would alter expression or affect primary
sequence of neighboring protein-coding genes (Bond et al., 2009;
Kraus et al., 2013).
Insertion of the transcriptional terminator sequence in the Evf2
locus results in a signiﬁcant, but incomplete loss of lncRNA tran-
script expression, likely resulting in a hypomorphic phenotype.
Loss of Evf2 results in an early decrease in GABAergic neurons in
the hippocampus and dentate gyrus in juvenile mice (Bond et al.,
2009). Although the deﬁcit inGABAergic neuron number is recov-
ered in in adult mice, loss of Evf2 results in reduced inhibition of
CA1 pyramidal neurons, likely the result of synaptic defects from
reduced Gad1 levels (Bond et al., 2009).
Similarly, in addition to mild defects resulting in craniofacial
anomalies, loss of Dlx1AS also affects the number of hippocam-
pal interneurons (Kraus et al., 2013). Loss of Dlx1AS results in
increased interneuron number, likely due to an increase in Dlx1
expression that triggers a corresponding increase of expression of
Mash1 (Kraus et al., 2013). Similar to Evf2 studies, early changes
in interneuron number are not maintained into adulthood in
Dlx1AS mice, suggesting compensatory mechanisms regulating
proper number of neurons (Kraus et al., 2013). Combined with
the observations of decreased Olig2 expression in Dlx1AS mutant
mice, Evf2 and Dlx1AS may be functioning to control levels of
the Dlx protein family to generate the proper proportion of oligo-
dendrocytes and GABAergic neurons generated from the bipotent
precursor (Bond et al., 2009; Kraus et al., 2013). Other studies have
indicated that lncRNAs can play a pivotal role in controlling neu-
ral versus oligodendrocyte fate decisions. This includes studies in
which Nkx2.2AS was overexpressed in ventral telencephalic pro-
genitors and was observed to drive oligodendrocyte speciﬁcation,
possibly by increasing Nkx2.2 levels (Tochitani and Hayashizaki,
2008).
Studies in zebraﬁsh have examined conserved lincRNAs that
display short sequences of high homology across evolution and
syntenic genomic localization (Ulitsky et al., 2011). The lncR-
NAs cyrano and megamind are highly expressed throughout the
developing nervous system. Morpholino knockdown of cyrano
and megamind results in zebraﬁsh with reduced brain and eye
size (Ulitsky et al., 2011). Additional phenotypes include neural
tube closing defects and reduced accumulation of the NeuroD-
GFP positive neurons in the developing eyes and brain (Ulitsky
et al., 2011). In examining the evolutionary conservation of func-
tion of lncRNAs, the researchers showed that the syntenic mouse
and human lncRNAs could partially rescue the observed pheno-
types from megamind inhibition. Additionally, the rescue using
mouse and human orthologs was dependent on expression of the
evolutionarily conserved sequence (Ulitsky et al., 2011). Interest-
ingly, the conserved sequence of cyrano was not sufﬁcient to rescue
decreased cyrano expression (Ulitsky et al., 2011). The conserved
sequence of cyrano, however, matched the consensus binding
sequence of miR-7, suggesting regulation of cyrano by miR-7, or
conversely, cyrano functioning as a miRNA decoy (Ulitsky et al.,
2011).
Similar to cyrano, the circRNA CDR1as also serves as a miR-7
decoy. CDR1as is highly conserved amongst mammals and con-
tains 63-consensus miR-7 binding sites conserved among two or
more species (Memczak et al., 2013). CDR1as is an antisense tran-
script to theCDR1 coding sequence and shares a similar expression
pattern to miR-7 during brain development. Over-expression of
the human CDR1as in zebraﬁsh, which have lost the entire CDR1
locus, results in a decreased size of the midbrain, similar to miR-
7 loss-of-function (Memczak et al., 2013). Together, these data
suggest that CDR1as acts as an endogenous “sponge” that atten-
uates the action of miR-7 on protein coding mRNAs through
competitive binding.
Like Six3os in retina, recent experiments examining the lncRNA
Paupar have uncovered another instance of a lncRNA that
cooperates with the neighboring protein-coding gene to regulate
transcription (Vance et al., 2014). Paurpar is localized ∼8.5 kb
upstream of the homeodomain factor Pax6, which regulates many
different aspects of CNS development. Interestingly, Paupar is
localized within the ﬁrst intron of the ncRNA Pax6os1, and is
generally coexpressed with Pax6 mRNA. However, Paupar inhi-
bition results in an increase in Pax6 expression. Comparing
changes in gene expression seen following knockdown of Pau-
par and Pax6 revealed many genes that showed similar changes
in expression, indicating that while Paupar regulates expression
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of Pax6 itself, Paupar is also likely to participate in the regu-
lation of Pax6 target genes (Vance et al., 2014). Using capture
hybridization analysis of RNA targets (CHART), the researchers
found that Paupar occupied >2500 genomic sites, localizing
to the promoters of many genes involved in stem cell mainte-
nance and neuronal development (Vance et al., 2014). Further
characterization indicated that Paupar and Pax6 co-occupy 71
different genomic loci, suggesting that both directly co-regulate
transcription of these genes (Vance et al., 2014). It remains to
be determined, however, if Paupar and Pax6 physically associate
to regulate target genes. It will also be important to exam-
ine the Pax6-independent functions of Paupar as a majority of
the genomic binding sites of Paupar are not co-occupied by
Pax6.
Recently, a small consortium has targeted multiple lincRNAs
for genetic deletion and begun reporting phenotypic analyses
(Sauvageau et al., 2013). In their studies, seven of the 18 lincR-
NAs targeted for knockout were shown to have human orthologs
that were dynamically expressed during directed neuronal differ-
entiation of ES cells (Sauvageau et al., 2013). In particular, the
deletion of the lincRNA linc-Brn1b was analyzed. Linc-Brn1b is
localized less than 10 kb downstream of the Brn1 gene, and is
transcribed from the OS of Brn1 (Sauvageau et al., 2013). Dele-
tion of linc-Brn1b results in mice with reduced Brn1 transcript
abundance. These mutants display features similar to Brn1/Brn2
double knockouts, including reducedproliferationof intermediate
progenitors within the sub-ventricular zone (SVZ) of the dorsal
telencephalon, reduced production of upper layer cortical neurons
and a reduction in total size of the barrel cortex (Sauvageau et al.,
2013). As linc-Brn1b was completely excised in the knockout stud-
ies and the phenotypes mimic some features of Brn1 knockouts,
the possibility exists that the observed phenotypes are partially the
result of decreasedBrn1 expressiondue to a lost enhancer sequence
within linc-Brn1b (Sauvageau et al., 2013). Further characteriza-
tion of linc-Brn1b and other lincRNA knockout lines generated in
these studies will continue to elicit the importance of lncRNAs in
neuronal development.
LncRNAs IN DISORDERS OF THE NERVOUS SYSTEM
Many groups are taking advantage of RNA-Seq and lncRNA
microarray technologies to identify altered transcript expression
levels between control and diseased states within various human
neurological and psychiatric disorders (Dharap et al., 2012, 2013;
Petazzi et al., 2013; Ziats and Rennert, 2013). While useful, with
few exceptions, these studies have not functionally implicated
these lncRNAs in disease progression (Petazzi et al., 2013; Ziats
and Rennert, 2013). Here we review the limited number of studies
that directly link altered lncRNA function to the development and
progression of neurological disease.
One of the better studied lncRNAs associated with human
disease is ANRIL (also known as CDKN2B-AS). Genome-wide
association studies have associated numerous polymorphisms on
human chromosome 9p21 that segregate with diseases includ-
ing cardiovascular disease, Type-2 diabetes, Alzheimer’s disease
(AD),primaryopen angle glaucoma, endometriosis, periodontitis,
and several cancers (reviewed in Congrains et al., 2013). Poly-
morphisms map to both the promoter and transcribed region of
ANRIL, including many transcription factor-binding sites located
throughout the locus. ANRIL has been shown to bind CBX7
and SUZ12 of the PRC1 and PRC2 complexes, respectively, to
regulate the histone modiﬁcation status of the nearby CDKN2A
and CDKN2B genes (Yap et al., 2010; Aguilo et al., 2011; Kotake
et al., 2011). As both increased and decreased ANRIL expression
levels correlate with disease states (Congrains et al., 2013), the
ﬁne control of CDKN2B/CDKN2A transcript abundance seems
paramount to normal development.
Kcna2AS is an antisense ncRNA to the voltage-gated potassium
channel Kcna2. Expression of Kcna2AS was observed in dorsal
root ganglia (DRG) and was expressed at higher levels in gan-
glia exhibiting lower levels of Kcna2 protein expression, or after
spinal nerve injury (Zhao et al., 2013). Spinal nerve injury causes
an increase of myeloid zinc ﬁnger protein 1 (MZF1) binding to
the proximal promoter of Kcna2AS, causing an increased expres-
sion of Kcna2AS with a concomitant decrease in Kcna2 transcript
and protein abundance (Zhao et al., 2013). Additional experi-
ments found that expression of Kcna2AS causes a decrease in
voltage-gated potassium currents and an increase in membrane
resting potential, suggesting that pain hypersensitivity or neuro-
pathic pain can be caused by altered Kcna2AS levels (Zhao et al.,
2013).
Recent studies have also implicated altered lncRNA expression
as associated with AD progression. AD is characterized by a pro-
gressive neurodegeneration that leads to memory and cognitive
impairment. A hallmark component of the pathological condi-
tion is the buildup of extracellular beta amyloidal plaques. The
amyloid precursor protein (APP) is cleaved in the initial and rate-
limiting stepbyβ-secretase enzyme (BACE1) to form the amyloidβ
precursor proteins Aβ 1–40 and Aβ 1–42. In pathological con-
ditions, the Aβ 1–42 proteins oligomerize and contribute to the
plaques that participate in AD (Abramov et al., 2004; Ohyagi et al.,
2005; Snyder et al., 2005; Esposito et al., 2006; Zhu et al., 2006;
Lacor et al., 2007; Matsuyama et al., 2007). As a result, it has been
suggested that BACE1 misregulation can contribute to excess Aβ
1–42 protein production and the development of amyloid plaques.
Recent work has identiﬁed an antisense transcript to BACE1
(BACE1-AS) that encodes a conserved∼2kb lncRNAwith a 104bp
overlap with the human BACE1 transcript (Faghihi et al., 2008).
Both overexpression and knockdown experiments indicated that
BACE1-AS is a positive regulator of BACE1 transcript and pro-
tein abundance (Faghihi et al., 2008). Mechanistically, BACE1-AS
stabilizes the BACE1 transcript, protecting it from RNA degra-
dation through RNA–RNA pairing of the BACE1-AS and BACE1
homologous regions (Faghihi et al., 2008). Importantly, BACE1-
AS and BACE1 transcripts were induced by many cell stressors
that are implicated in the initiation of AD, suggesting a direct
mechanism by which cell stress can lead to increased Aβ precur-
sor protein production (Faghihi et al., 2008). The importance of
BACE1-AS in AD was further supported through examinations
of primary tissues from multiple brain regions, where BACE1-
AS transcript abundance was elevated twofold in conﬁrmed AD
patient brain samples compared to age- and sex-matched con-
trols (Faghihi et al., 2008). Further characterization of BACE1-AS
in a transgenic mouse model of AD indicated that BACE1-
AS inhibition reduces the insoluble fraction of Aβ 1–40 and
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Aβ 1–42 precursor proteins (Modarresi et al., 2011), suggesting
that increased BACE1-AS expression does directly contribute to
AD pathology.
Other aspects of AD are also potentially regulated through
lncRNA function. Recent work on neurotrophin levels in dis-
eases of the brain have indicated that reduced neurotrophin
levels (BNDF and glial derived neurotrophic factor – GDNF)
correlate with the onset of neurodegenerative disorders such
as Parkinson’s disease, AD, and HD (reviewed in Allen et al.,
2013). This has led to potential therapeutics aimed at increas-
ing neurotrophin levels (Weinreb et al., 2007; Straten et al., 2011;
Allen et al., 2013). However, as both BDNF and GDNF dis-
play complex splicing regulation (Airavaara et al., 2011; Modar-
resi et al., 2012), other mechanisms of therapeutic intervention
than exogenous neurotrophin replacement may be better suited
to treating the diseases. Interestingly, both BDNF and GDNF
have corresponding anti-sense or OS transcripts (BDNF-AS and
GDNF-OS), however, one of the three GDNF-OS transcripts
is likely protein coding (Airavaara et al., 2011). Knockdown of
either BDNF-AS or GNDF-OS results in an increase in corre-
sponding protein-coding gene transcript abundance, implying
that these lncRNAs negatively regulate neurotrophin expression
(Modarresi et al., 2012). Further characterization of BDNF-AS
indicates that BDNF-AS recruits EZH2 and the PRC2 complex
to the BDNF promoter to repress BDNF transcription through
H3K27me3 histone modiﬁcations (Modarresi et al., 2012). Com-
bined with studies in which treatment with exogenous BDNF res-
cued HD phenotypes in mice (Xie et al., 2010), these experiments
suggest that inhibition of neurotrophin antisense transcripts
may provide a novel target for treatment of neurodegenerative
disease.
LncRNAs have also been implicated in nervous system dis-
orders through their role in pre-mRNA splicing. The lncRNAs
Gomafu and Malat1 are both highly expressed in the nervous sys-
temand regulate splicing through interactionswith splicing factors
(Sone et al., 2007; Tripathi et al., 2010; Tsuiji et al., 2011; Zong
et al., 2011). Interestingly, aberrant splicing of the genes DISC1
and ERBB4, among others, is associated with disease pathol-
ogy in schizophrenia (SZ; Law et al., 2007; Nakata et al., 2009;
Morikawa and Manabe, 2010). Additionally, the Gomafu-bound
splicing factor QKI is downregulated in SZ brains and is pro-
posed to contribute to disease pathology (Aberg et al., 2006a,b;
Haroutunian et al., 2006; McCullumsmith et al., 2007). Recently,
Gomafu has been shown to interact with multiple splicing fac-
tors, including a strong interaction with QKI (Barry et al., 2013).
Gomafu expression is also signiﬁcantly decreased shortly after neu-
ronal depolarization in the cortical neurons in mice, and in human
inducedpluripotent stemcell (iPSC)-derivedneurons (Barry et al.,
2013). Combined with GWAS studies linking Gomafu with eye
movement disorders in SZ (Takahashi et al., 2003), this led to the
hypothesis that loss of function of Gomafu may directly contribute
to SZ disease pathology. Indeed,Gomafu is signiﬁcantly reduced in
superior temporal gyrus of SZ brain samples compared to controls
(Barry et al., 2013). Knockdown of Gomafu in iPSC neurons also
results in an increase in rare splice variants of DISC1 and ERBB4
(Barry et al., 2013), matching splicing patterns observed in vivo
from human SZ brains (Law et al., 2007; Nakata et al., 2009).
With the increased use of whole exome sequencing and
copy number variations (CNV) for genetic analysis of patients
with neurological diseases, our understanding of the impor-
tance of lncRNAs in neurodevelopment will only be further
increased. For example, one patient that displayed a cog-
nitive developmental delay possessed a chromosomal translo-
cation that affected linc00299 (Talkowski et al., 2012). Fur-
ther examinations of patient databases identiﬁed an additional
four patients that displayed developmental delay and disrup-
tion of the linc00299 locus (Talkowski et al., 2012), suggest-
ing that linc00299 is vital for proper neuronal development.
Further characterization of lncRNA function in animal mod-
els and in vitro will continue to expand our knowledge on
the importance of lncRNAs in both human development and
disease.
CONCLUSION
Advances in sequencing technologies and the appreciation of
functional non-coding elements have resulted in the rapid iden-
tiﬁcation of a plethora of lncRNAs expressed in both vertebrate
and invertebrates, alike. Systematic characterization of tempo-
rally and spatially restricted expression patterns in the developing
nervous system has provided the groundwork for hypotheses
regarding lncRNA function. As we understand more about the
mechanism by which lncRNAs are regulating transcription, we
are beginning to understand the biological signiﬁcance of what
once was labeled as “junk DNA.” Many lncRNAs regulate tran-
scription through regulation of epigenetics and interactions with
chromatin-modifying complexes, although the mechanism by
which lncRNAs are recruited to speciﬁc genomic loci is still
unclear. Recently developed technologies have the potential to
greatly expand our understanding of the mechanism by which
lncRNAs function. The advent of techniques such as ChIRP
and CHART allow for systematic characterization of DNA bind-
ing sites of lncRNAs throughout the genome (Chu et al., 2011;
Simon et al., 2011). Additionally, protein arrays, as used to iden-
tify Six3os binding partners (Rapicavoli et al., 2011), allow for an
unbiased approach to identifying physiologically relevant protein
binding partners. These techniques will further our understand-
ing of how lncRNAs function as molecular scaffolds and will
enable the functional characterization of lncRNAs working in
trans. While not the focus of this review, it is also essential to
consider the function of lncRNAs that display cytoplasmic expres-
sion, which represent a large fraction of lncRNAs and whose
function is poorly understood (reviewed in Batista and Chang,
2013). Further characterization of lncRNA–protein interactions
through protein arrays will help facilitate these discoveries. As
many cytoplasmic lncRNAs associate with ribosomes (van Heesch
et al., 2014), it is intriguing to speculate that lncRNAs function
as scaffolds to regulate localized protein synthesis and/or degra-
dation, a concept vitally important in the control of synaptic
function.
As we continue to understand the molecular basis of lncRNA
function, it is imperative that studies move from in vitro, homo-
geneous cell populations and begin to examine the consequence
within individual cell types. Neuronal diversiﬁcation has exhibited
a multitude of examples in which transcriptional regulation and
www.frontiersin.org June 2014 | Volume 5 | Article 164 | 13
Clark and Blackshaw lncRNAs in neural development
cell-fate decisions are very context and cell-type speciﬁc. There-
fore, it is plausible that individual lncRNAs may display diverse
functions that are dependent on their spatial and temporal expres-
sion pattern. Inherent to the examination of speciﬁc cell types is
that epigenetic marks may display vast temporal and/or cell-type
speciﬁc signatures. In vivo experiments continue to shed light on
the importance of lncRNA function throughout neuronal devel-
opment. As mouse models for genetic loss of lncRNAs such as
Evf2, Dlx1AS, Malat1, and Neat1 produce modest phenotypes or
fail to recapitulate phenotypes observed in knockdown experi-
ments (Bond et al., 2009; Zhang et al., 2012; Kraus et al., 2013), it
is important to consider that lncRNAs may have evolved to func-
tion as a ﬁne-tuning mechanism to ensure proper regulation of
neuronal cell type proportions in the highly complex mammalian
nervous system. Genetic compensation may mask phenotypes
resulting from conventional gene knockout approaches, which
conditional or acute loss of function studies may readily detect.
Furthermore, efforts need to be made to carefully examine genetic
models of lncRNA loss-of-function, however, being constantly
mindful of the fact that many lncRNAs overlap conserved regula-
tory elements that may have function independent of the lncRNA
itself, complicating interpretation of any observed phenotypes.
Further exploration of lncRNA function will only continue to add
toour appreciationof the complexity of transcriptional regulation,
especially within the context of the seemingly endlessly complex
development of the nervous system.
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